Samson Chan is specialized in the Hong Kong capital market, with a particular focus on Hong Kong initial public offerings and other equity-related transactions. He has advised numerous clients across various sectors including TMT, pharma, biotech and retail on their listings on the Stock Exchange of Hong Kong Limited.
Samson has been recognised as a Notable Practitioner in China Capital Markets: Equity by IFLR1000 2022, 2021, 2020 & 2019.
News and client work
Career and qualifications
- Admitted as a solicitor in Hong Kong 2014
- Joined Clifford Chance 2017
Awards and citations
- Recognised as a Notable Practitioner in China Capital Markets: Equity
IFLR1000 2022, 2021, 2020 & 2019